Picture of Meso Numismatics logo

MSSV Meso Numismatics Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapTurnaround

Momentum

Relative Strength (%)
1m+8.03%
3m-8.41%
6m+231.2%
1yr+221.85%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-34.17%
50d MA-8.19%
200d MA+47.04%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-137.77%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Meso Numismatics EPS forecast chart

Profile Summary

Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    March 31st, 2024
    Incorporated
    March 16th, 2001
    Public Since
    December 28th, 2001
    No. of Shareholders
    142
    No. of Employees
    1
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    12,493,938

    MSSV Share Price Performance

    Upcoming Events for MSSV

    Similar to MSSV

    Picture of Acorda Therapeutics logo

    Acorda Therapeutics

    us flag iconPink Sheets on Nasdaq

    Picture of Actavia Life Sciences logo

    Actavia Life Sciences

    us flag iconPink Sheets on Nasdaq

    Picture of Acura Pharmaceuticals logo

    Acura Pharmaceuticals

    us flag iconPink Sheets on Nasdaq

    Picture of Adhera Therapeutics logo

    Adhera Therapeutics

    us flag iconPink Sheets on Nasdaq

    Picture of Ramoil Management logo

    Ramoil Management

    us flag iconPink Sheets on Nasdaq

    FAQ